46.46.Z - Wholesale of pharmaceutical goods
20.42.Z - Manufacture of perfumes and toilet preparations
21.20.Z - Manufacture of medicines and other pharmaceutical products
46.45.Z - Wholesale of perfume and cosmetics
47.73.Z - Dispensing chemist in specialised stores
47.75.Z - Retail sale of cosmetic and toilet articles in specialised stores
72.11.Z - Research and experimental development on biotechnology
72.19.Z - Other research and experimental development on natural sciences and engineering
74.90.Z - Other professional, scientific and technical activities not elsewhere classified
82.92 - Packaging activities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 0,9 | 0,2 | 0,7 | 204,8 |
EBITDA | 0,3 | 0,8 | 213 | |
Short time liabilities | 0,7 | 0,5 | 0,4 | -24,9 |
Equity capital | 1,6 | 1,8 | 2,4 | 30,9 |
Operating profit (EBIT) | 1 | 0,2 | 0,8 | 235 |
Assets | 2,3 | 2,3 | 2,8 | 19,4 |
Net profit (loss) | 0,8 | 0,2 | 0,6 | 160,4 |
Cash | 0,2 | 0,2 | 0,4 | 117,5 |
Liabilities and provisions for liabilities | 0,7 | 0,5 | 0,4 | -24,9 |
Net income from sale | 7,3 | 7,2 | 18,3 | 153,3 |
Working assets | 2,2 | 2,2 | 2,7 | 20,6 |
Depreciation | 0 | 0 | -31,1 | |
% | % | % | p.p. | |
Profitability of capital | 11,9 | 23,6 | 11,7 | |
Equity capital to total assets | 70,5 | 79,4 | 87 | 7,6 |
Gross profit margin | 12,5 | 3,3 | 4 | 0,7 |
EBITDA Margin | 3,5 | 4,3 | 0,8 | |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 34 | 24 | 7 | -17 |
Current financial liquidity indicator | 4.716860771179199 | 7.579111099243164 | 2,9 | |
Net dept to EBITDA | -0.7319836616516113 | -0.5141183733940125 | 0,2 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane